Immunosuppressive effects of rifampicin on a tuberculosis patient after renal transplant
Pakistan Journal of Medical Sciences. 2011; 27 (3): 720-722
en Inglés
| IMEMR
| ID: emr-123994
ABSTRACT
Rifampicin is a semisynthetic derivative of rifamycin B and inhibits the growth of a variety of bacteria. Rifampicin causes an increase in corticosteroid clearance, and a decrease in the blood concentrations of calcineurin inhibitors by inducing Cytochrome P[450] 3A4 in the liver. It is generally acknowledged that a substantial increase in the dosage of calcineurin inhibitors is required to achieve the efficacious target concentrations and avoid graft rejection. We report a case of patient who received a living-related donor renal transplant with stable renal function during the rifampicin based anti-tuberculosis treatment, even the blood concentration of tacrolimus [FK506] decreased. Interestingly, acute rejection was observed at the end of anti-tuberculosis treatment, even the blood concentration of FK506 was reduced to target level
Buscar en Google
Índice:
IMEMR (Mediterraneo Oriental)
Asunto principal:
Rifampin
/
Tuberculosis
/
Terapia de Inmunosupresión
/
Trasplante de Riñón
/
Calcineurina
/
Rechazo de Injerto
/
Inmunosupresores
/
Antituberculosos
Tipo de estudio:
Informe de Casos
Límite:
Femenino
/
Humanos
Idioma:
Inglés
Revista:
Pak. J. Med. Sci.
Año:
2011
Similares
MEDLINE
...
LILACS
LIS